GlassScriptPhysician profile
Shabrez Tariq
NPI 1558542068
$2,679.96
in general payments reported to CMS, 2019-2025
28 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,333 · 2020: $291 · 2021: $241 · 2022: $259 · 2023: $156 · 2024: $244 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,083.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $261.04 | 2019-2025 | Relistor |
| Nevro Corp. | $245.25 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $113.62 | 2023-2025 | Zilretta, Exparel, Iovera |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $88.52 | 2022-2024 | Xtampza, Belbuca |
| Relievant Medsystems, INC. | $80.62 | 2021 | |
| Innovation Technologies INC | $76.06 | 2024-2025 | Irrisept |
| Abbott Laboratories | $62.33 | 2021 | |
| Avanos Medical | $49.97 | 2022 | |
| Amgen INC. | $49.28 | 2020 | |
| Abbvie INC. | $48.48 | 2025 | |
| Grt US Holding, INC. | $47.34 | 2020 | |
| Medtronic USA, INC. | $41.78 | 2019 | |
| Scilex Pharmaceuticals INC. | $37.54 | 2022-2023 | Ztlido |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $36.90 | 2019 | |
| Redhill Biopharma INC. | $33.72 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $33.49 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $27.41 | 2021 | |
| Boston Scientific Corporation | $24.61 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $24.27 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.42 | 2025 | |
| Arbor Pharmaceuticals, INC. | $19.19 | 2020 | |
| Ibsa Pharma INC. | $17.01 | 2023 | Tirosint, Licart |
| Mdd US Operations, LLC | $16.96 | 2020 | |
| Electronic Waveform Lab, INC. | $16.02 | 2022 | |
| Protega Pharmaceutials INC | $12.84 | 2023 | Roxybond |
| Epimed International, INC | $10.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shabrez Tariq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.